Hypnosis and alopecia areata: Long-term beneficial effects on psychological well-being

Acta Dermato-Venereologica

Volumn 91, Issue 1, 2011, Pages 35-39

  Willemsen, Ria ^a   Haentjens, Patrick ^b   Roseeuw, Diane ^a   Vanderlinden, Johan ^c  

^a Department of Dermatology ^*  (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Alexithymia; Alopecia areata; HRQOL; Hypnosis

Indexed keywords

ADULT; ALEXITHYMIA; ALOPECIA AREATA; ANXIETY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; HYPNOSIS; MALE; MENTAL DISEASE; MOTIVATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RATING SCALE; SHORT FORM 36; TREATMENT DURATION;

ADOLESCENT; ADULT; AFFECTIVE SYMPTOMS; AGED; ALOPECIA AREATA; EMOTIONS; FEMALE; HEALTH STATUS; HUMANS; HYPNOSIS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 78751561909     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1012     Document Type: Article

References (23)

1. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007; 117: 2019-2027.
2. Willemsen R, Roseeuw D, Vanderlinden J. Alexithymia and dermatology: the state of the art. Int J Dermatol 2008; 4: 903-910.
3. Koo JY, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 1994; 33: 849-850.
4. García-Hernández MJ, Ruiz-Doblado S, Rodriguez-Pichardo A, Camacho F. Alopecia areata, stress and psychiatric disorders: a review. J Dermatol 1999; 26: 625-632.
5. Brajac I, Tkalcic M, Dragojevic DM, Gruber F. Roles of stress, stress perception and trait-anxiety in the onset and course of alopecia areata. J Dermatol 2003; 30: 871-878.
6. Perini G, Zara M, Cipriani R, Carraro C, Preti A, Gava F, et al. Imipramine in alopecia areata. A double-blind, placebo-controlled study. Psychother Psychosom 1994; 61: 195-198.
7. Ruiz-Doblado S, Carrizosa A, García-Hernández MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol 2003; 42: 434-437.
8. Cipriani R, Perini IG, Rampinelli S. Paroxetine in alopecia areata. Int J Dermatol 2001; 40: 600-601.
9. Willemsen R. Haentjens P, Roseeuw D, Vanderlinden J. Hypnosis in refractory alopecia areata significantly improves depression, anxiety and life quality but not hair regrowth. J Am Acad Dermatol 2010; 62: 517-518.
10. Taylor GJ, Bagby RM, Parker JD. The 20-Item Toronto Alexithymia Scale. IV. Reliability and factorial validity in different languages and cultures. J Psychosom Res 2003; 55: 277-283.
11. Derogatis LR, Melissaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13: 595-605.
12. Derogatis LR, Cleary PA. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br J Soc Clin Psychol 1977; 16: 347-356.
13. Lipman RS, Covi L, Shapiro AK. The Hopkins Symptom Checklist (HSCL) - factors derived from the HSCL-90. J Affect Disord 1979; 1: 9-24.
14. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992; 30: 473-483.
15. de Korte J, Mombers FMC, Sprangers MA, Bos JD. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002; 138: 1221-1227.
16. Nijsten TEC, Sampogna F, Chren MG, Abeni DD. Testing and reducing skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 2006: 126, 1244-1250.
17. Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007; 127: 2726-2739.
18. Willemsen R, Vanderlinden J. Hypnotic approaches for alopecia areata. Int J Clin Exp Hypn 2008; 56: 318-833.
19. Cohen J. The t-test for means. In: Cohen J. Statistical Power Analysis for the Behavioral Sciences. Chapter 2. 2nd edn. Hillsdale, NJ: Lawrence Earlbaum Associates, Inc., Publishers, 1988; p. 19-74.
20. Rø O, Martinsen EW, Hoffart A, Rosenvinge JH. Short-term follow-up of adults with long standing anorexia nervosa or non-specified eating disorder after inpatient treatment. Eat Weight Disord 2004; 9: 62-68.
21. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008; (2): CD004413.
22. Gulec AT, Tanriverdi N, Duru, C, Saray Y, Akcali C. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004; 43: 352-356.
23. Gay M, Hanin D, Luminet O. Effectiveness of an hypnotic imagery intervention on reducing alexithymia. Contempor Hypnos 2008; 25: 1-13.